Biological activity of for-Met-Leu-Phe-OMe analogs: Relevant substitutions specifically trigger killing mechanisms in human neutrophils

被引:10
作者
Cavicchioni, G
Fraulini, A
Turchetti, M
Varani, K
Falzarano, S
Pavan, B
Spisani, S
机构
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dept Clin & Expt Med, Pharmacol Unit, I-44100 Ferrara, Italy
[3] Univ Ferrara, Dept Biol, Physiol Sect, I-44100 Ferrara, Italy
[4] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy
关键词
N-formylmethionyl peptide; neutrophil; human; chemotaxis; superoxide anion generation; lysozyme release; receptor binding;
D O I
10.1016/j.ejphar.2005.02.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two analogs of the prototypical peptide for-Met-Leu-Phe-OMe (fMLP-OMe), for-Gln-Tyr-Phe-OMe (1) and for-Gln-Tyr-Tyr-OMe (2), carrying unusual hydrophilic residues, were synthesized in order to investigate whether they provoked specific biological responses, as well as intracellular calcium mobilization, in human neutrophils. Whereas neither compound stimulates chemotaxis, both are able to elicit lysosomal enzyme production. However compound 1 is able to trigger copious superoxide anion production while compound 2 only elicits minor superoxide anion production. In binding experiments on formylpeptide receptors, the newly synthesized compounds for-Ght-Tyr-Phe-OMe (1) and for-Gln-Tyr-Tyr-OMe (2) showed affinity values in the micromolar range. These derivatives demonstrate inability to find a positive contribute from single substitutions. A very important result of this research is the evidence of the ability of the formyl group alone to trigger the primary target of the human neutrophil activity, i.e. killing mechanisms, by activating the specific receptor conformation. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 39 条
[1]   SYNTHESIS AND USE OF A NOVEL N-FORMYL PEPTIDE DERIVATIVE TO ISOLATE A HUMAN N-FORMYL PEPTIDE RECEPTOR CDNA [J].
BOULAY, F ;
TARDIF, M ;
BROUCHON, L ;
VIGNAIS, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) :1103-1109
[2]  
Cavicchioni G, 1998, ARCH PHARM, V331, P368, DOI 10.1002/(SICI)1521-4184(199811)331:11<368::AID-ARDP368>3.3.CO
[3]  
2-2
[4]   Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2 [J].
Cavicchioni, G ;
Turchetti, M ;
Spisani, S .
JOURNAL OF PEPTIDE RESEARCH, 2002, 60 (04) :223-231
[5]   A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs [J].
Cavicchioni, G ;
Spisani, S .
JOURNAL OF PEPTIDE RESEARCH, 2001, 58 (03) :257-262
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]  
Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO
[8]  
2-6
[9]  
DENTINO AR, 1991, J BIOL CHEM, V266, P18460
[10]   DIFFERENTIAL STIMULATION OF NEUTROPHIL FUNCTIONS BY PYRITHIOXINE [J].
ELFERINK, JGR ;
DEKOSTER, BM .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1993, 15 (05) :641-646